Emergency Medicine · Toxicology
The facts most likely to be tested
The classic opioid toxidrome triad consists of depressed mental status, respiratory depression, and miosis (pinpoint pupils).
Respiratory depression is the primary cause of mortality in opioid overdose and is defined by a decreased respiratory rate or tidal volume.
Naloxone is the competitive opioid receptor antagonist of choice for reversing life-threatening respiratory depression.
Pupillary constriction (miosis) is a highly specific physical exam finding, though meperidine overdose may present with mydriasis due to its anticholinergic properties.
Pulmonary edema (non-cardiogenic) is a frequent complication of severe opioid overdose, often presenting with hypoxia and diffuse crackles on auscultation.
Naloxone has a shorter half-life than many opioids, necessitating prolonged observation to monitor for rebound respiratory depression.
Bowel sounds are typically decreased or absent in opioid overdose due to the drug's effect on mu-opioid receptors in the gastrointestinal tract.
Vignette unlocked
A 28-year-old male is brought to the emergency department by EMS after being found unresponsive in a public restroom. On physical exam, the patient is somnolent with a respiratory rate of 6 breaths/minute and pinpoint pupils. Auscultation of the lungs reveals diffuse crackles bilaterally, and oxygen saturation is 84% on room air. The patient has decreased bowel sounds on abdominal exam.
What is the most appropriate initial management for this patient?
Intravenous naloxone
The patient presents with the classic triad of opioid overdose (depressed mental status, respiratory depression, and miosis), requiring immediate reversal with naloxone to restore adequate ventilation.
Full handout
High yield triage
Etiology / Epidemiology
Common in chronic opioid users and poly-substance abuse. High risk during post-abstinence periods due to loss of tolerance.
Clinical Manifestations
Classic triad: miosis, respiratory depression, and CNS depression. Look for pinpoint pupils.
Diagnosis
Clinical diagnosis based on history and physical exam. No gold standard lab test required for acute management.
Treatment
Naloxone is the first-line reversal agent. Acute withdrawal is the primary risk of over-administration.
Prognosis
Excellent if treated early. Non-cardiogenic pulmonary edema is the most common life-threatening complication.
Full handout
Epidemiology & Etiology
Incidence is highest among patients with opioid use disorder or those prescribed high-dose chronic pain management. Risk spikes significantly following detoxification or release from incarceration due to decreased tolerance. Accidental ingestion in children or intentional overdose in adults are common clinical scenarios.
Pertinent Anatomy
Opioids primarily act on the mu-opioid receptors located in the brainstem and thalamus. Depression of the medullary respiratory center leads to the hallmark hypoventilation. The Edinger-Westphal nucleus is stimulated, resulting in parasympathetic-mediated miosis.
Pathophysiology
Opioids inhibit the release of excitatory neurotransmitters, causing profound CNS depression. The primary cause of death is respiratory failure secondary to decreased sensitivity of the respiratory center to hypercapnia. Secondary effects include decreased gastrointestinal motility and peripheral vasodilation.
Clinical Manifestations
The classic opioid triad includes respiratory depression (RR < 12), CNS depression (lethargy to coma), and pinpoint pupils. Hypoxia and bradycardia are common in severe cases. Note that meperidine is a notable exception that may cause mydriasis due to its anticholinergic properties.
Diagnosis
Diagnosis is clinical. Pulse oximetry and ABG are used to assess the severity of respiratory failure. A urine toxicology screen is helpful for identifying co-ingestants but does not guide acute management. Fingerstick glucose is mandatory to rule out hypoglycemia as a mimic.
Treatment
Administer Naloxone (0.4–2.0 mg IV/IM/IN) to restore respiratory drive. Acute opioid withdrawal (agitation, vomiting, diarrhea) is a risk if the dose is too high. If the patient is apneic, prioritize bag-valve-mask ventilation before pharmacological reversal. Monitor for at least 2–4 hours post-reversal due to the short half-life of naloxone.
Prognosis
Most patients recover fully with prompt airway management. Non-cardiogenic pulmonary edema is a frequent complication requiring mechanical ventilation. Patients must be monitored for re-sedation as the effects of the opioid may outlast the naloxone.
Differential Diagnosis
Benzodiazepine overdose: usually presents with normal pupils and less severe respiratory depression
Clonidine toxicity: presents with bradycardia and hypotension but often mimics opioid miosis
Hypoglycemia: must be ruled out via fingerstick in all comatose patients
Carbon monoxide poisoning: look for cherry-red skin and history of smoke inhalation
Serotonin syndrome: look for hyperreflexia and clonus, which are absent in opioid overdose